Ducabr Plus Tablet 60/10/12.5 Milligrams

Adult dose

This drug is taken once daily with water, regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). For patients whose blood pressure is not controlled with the combination therapy of pimasartan potassium/amlodipine, administer this drug at a dosage of 30/5/12.5 milligrams, adjusting the dose based on the patient's blood pressure response at intervals of more than 2 weeks. The maximum dosage of this drug is 60/10/25 mg.

This drug may cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients with a history of allergies to this drug or similar medications, or with severe liver or kidney dysfunction should not take this medication. Patients with decreased blood volume, kidney issues, valvular heart disease, or hypotension should use this medication with caution and monitor their condition frequently while on it. This drug may cause side effects such as dizziness, headache, dyspepsia, and lowered blood pressure, so if symptoms are severe, medical consultation is necessary. This drug can interact with other antihypertensive medications, certain diuretics, potassium supplements, etc., so it is important to inform your healthcare provider of any other medications being taken. Women who are pregnant or breastfeeding should not take this drug, and if breastfeeding, they should either discontinue nursing or stop taking the medication. The safety and efficacy of this drug in children or adolescents under the age of 18 have not been established. Elderly patients may be more sensitive to this medication, so it is recommended to start at a lower dosage and carefully monitor the condition. In the event of an overdose, symptoms such as lower blood pressure, cardiac arrhythmias, and electrolyte imbalances may occur, necessitating immediate medical attention for adequate treatment. This medication must be kept out of reach of children and not be transferred to other containers.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headaches, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urinary changes

Mild side effects

Dizziness, headache, numbness, increased creatine phosphokinase (CPK) levels, dyspepsia, rhinitis, confusion, rectal bleeding, dental caries, duodenitis, gastritis, hemorrhoids, stomatitis, increased alanine aminotransferase (ALT) levels, increased blood glucose, chest pain, edema, peripheral edema, cystitis, hyperuricemia, hypokalemia, hyponatremia, palpitations, muscle cramps, hypotension, facial flushing, insomnia, flushing, orthostatic dizziness, fainting, sedation

This drug should be stored in a tightly closed container to prevent exposure to air or moisture. It is advisable to maintain storage temperatures between 1 to 30 degrees Celsius at room temperature.

Appearance

Orange, oval film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP x 3)], 30 tablets/bottle, 300 tablets/bottle